Czechia· CZ-0167065

SCINTIMUN

A 99mtc-technetium-antigranulozyten antikörper product containing besilesomab, registered in Czechia by Telix Innovations, Herstal. The same ATC class is registered in 9 of our 19 countries.

ATC V09HA03

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSCINTIMUNATCV09HA03REGISTER NO.CZ-0167065PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

99mtc-technetium-antigranulozyten antikörper is registered in 9 of 19 countries.

Countries holding a registration under ATC V09HA03 (99mtc-technetium-antigranulozyten antikörper), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose

99mtc-technetium-antigranulozyten antikörper · ATC V09HA03

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BESILESOMAB
Manufacturer
Telix Innovations, Herstal
Country
Czechia (CZ)
ATC code
V09HA03
ATC class
99mTc-Technetium-Antigranulozyten Antikörper
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

99mtc-technetium-antigranulozyten antikörper in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 99mtc-technetium-antigranulozyten antikörper products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Scintimun
  • Liechtenstein · Scintimun
  • Norway · Scintimun

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb48c385-ed7f-465f-910f-59206295de2b
GET /v1/drugs/eb48c385-ed7f-465f-910f-59206295de2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "RAD KIT",
  "source": "sukl",
  "strength": "1MG",
  "pack_size": "1+1",
  "substance": "BESILESOMAB",
  "cz_kod_sukl": "0167065",
  "product_type": "RA",
  "substance_codes": "17269",
  "registration_state": "R",
  "registration_number": "EU/1/09/602/001"
}

See everything about 99mtc-technetium-antigranulozyten antikörper.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.